A registry for gastrointestinal endoscopy reports and videos
Official title: ColoReg: A Register for Gastrointestinal Endoscopy Reports and Examination Videos
Run by Wuerzburg University Hospital · NCT06920680 · Data updated 2026-11-12
This study is collecting and analyzing data from gastrointestinal endoscopy procedures to see how well current practices prevent and treat colorectal cancer, while also using the videos to help train doctors better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1834 (estimated) |
| Sponsor | Wuerzburg University Hospital Academic / other |
| Locations | 2 sites (Stuttgart, Baden-Wurttemberg and 1 other locations) |
| Status | Recruiting |
| Started | October 1, 2024 |
| Main results expected | October 2026 |
| Study ends | October 2027 |
| Registry record updated | December 22, 2025 |
| Trial ID | NCT06920680 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who require diagnostic or therapeutic colonoscopy.
✕Probably not a fit
Patients who do not need a colonoscopy or have contraindications for the procedure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect and analyze data from gastrointestinal endoscopy procedures, specifically focusing on colorectal cancer prevention and treatment. By tracking treatment methods, outcomes, and adverse events, the study seeks to validate whether clinical study results align with real-world practices. Additionally, the collected examination videos will be utilized to enhance medical training for doctors, providing them with updated and diverse teaching materials. The findings will also be made accessible to the scientific community to support ongoing research and education.
Why it matters
Potential benefit: If successful, this study could improve the quality of colorectal cancer prevention and treatment through enhanced training and standardized documentation.
How similar studies have gone: While the approach of using real-world data and video documentation for training is promising, similar studies have shown varying degrees of success, making this a potentially novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Indication for diagnostic or therapeutic colonoscopy Exclusion Criteria: \-
Where it's running
-
Robert Bosch Krankenhaus
Stuttgart, Baden-Wurttemberg, Germany Recruiting -
University Hospital Würzburg
Würzburg, Bavaria, Germany Recruiting
Study contacts
- Study coordinator: Thomas J. Lux, Dr. med. M. Sc.
- Email: lux_t1@ukw.de
- Phone: +49 931 201 40247
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Liver transplantation for colorectal cancer with liver metastases
This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.
-
LTZ-232: a first-in-human test in advanced colorectal and other solid tumors
A first-in-human study tests LTZ-232, a new therapy for adults with unresectable or metastatic colorectal cancer and other solid tumors that have not responded to standard treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.